Prospective multicentric randomized study comparing in IVF-embryo transfer the injection of a single dose of GnRH antagonist (Cetrorelix) to a depot formula of GnRH agonist (triptorelin) in a long protocol

被引：0
|
作者：
Olivennes, F
Belaisch-Allart, J
Emperaire, JC
Hedon, B
Alvarez, S
Moreau, L
Nicollet, B
Zorn, JR
Bouchard, P
Frydman, R
机构：
[1] A Beclere Hosp, Dept Obstet Gynecol, F-92140 Clamart, France
[2] R Pellegrin Hosp, F-33076 Bordeaux, France
[3] J Rostand Hosp, F-92310 Sevres, France
[4] A de Villeneuve Hosp, F-34295 Montpellier, France
[5] Tenon Hosp, F-75020 Paris, France
[6] Baudelocque Hosp, F-75014 Paris, France
[7] Inst Rhone Alpin Bron, Bron, France
[8] Hop St Antoine, F-75012 Paris, France
来源：
HUMAN REPRODUCTION | 1998年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P089
引用
收藏
页码：174 / 174
页数：1
相关论文
共 50 条
  • [1] A prospective randomized study comparing the use of HMG versus rec-FSH with the single dose GnRH antagonist (Cetrorelix) protocol in IVF-embryo transfer
    Olivennes, F
    Belaich-Allart, J
    Alvarez, S
    Bouchard, P
    Frydman, R
    HUMAN REPRODUCTION, 1999, 14 : 61 - 61
  • [2] Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with GnRH antagonist (cetrorelix) or a short protocol of the GnRH agonist (triptorelin).
    Ma, C.
    Qiao, J.
    Liu, P.
    FERTILITY AND STERILITY, 2006, 86 : S407 - S407
  • [3] The use of a GnRH antagonist (Cetrorelix®) in a single dose protocol in IVF-embryo transfer:: a dose finding study of 3 versus 2 mg
    Olivennes, F
    Alvarez, S
    Bouchard, P
    Fanchin, R
    Salat-Baroux, J
    Frydman, R
    HUMAN REPRODUCTION, 1998, 13 (09) : 2411 - 2414
  • [4] Prospective,randomized,controlled study of in vitro fertilization-embryo transfer with single-dose and multiple-dose GnRH antagonist (cetrorelix) or a short protocol of the GnRH agonist (triptorelin) in Chinese women
    腊晓琳
    马彩虹
    刘平
    陈贵安
    乔杰
    生殖医学杂志, 2009, 18(S2) (S2) : 15 - 19
  • [5] The use of a GnRH antagonist (Cetrorelix) in a single-dose protocol in IVF-embryo transfer: a dose-finding study of 3 versus 2 mg
    Olivennes, F
    Alvarez, S
    Bouchard, P
    Fanchin, R
    Salat-Baroux, J
    Frydman, R
    HUMAN REPRODUCTION, 1998, 13 : 69 - 69
  • [6] The use in IVF-embryo transfer of a new GnRH antagonist (Cetrorelix) in natural cycles associated with minimal stimulation
    Olivennes, F
    Rongières-Bertrand, C
    Righini, C
    Fanchin, R
    Taïeb, J
    Bouchard, P
    Frydman, R
    HUMAN REPRODUCTION, 1998, 13 : 195 - 195
  • [7] Single dose GnRH-antagonist cetrorelix vs. long protocol GnRH-agonist in patients undergoing controlled ovarian hyperstimulation for IVF.
    Hamori, M
    Antoni, K
    FERTILITY AND STERILITY, 2001, 76 (03) : S147 - S148
  • [8] Controlled ovarian stimulation using GnRH antagonist Cetrorelix single dose protocol: A comparative study with GnRH agonist treatment.
    Olivennes, J
    Samama, M
    Kadoch, IJ
    Fanchin, R
    Righini, C
    Frydman, R
    FERTILITY AND STERILITY, 2002, 78 (03) : S177 - S177
  • [9] GnRH-agonist versus GnRH-antagonist in elective single embryo transfer IVF cycles
    Fatemi, H. Mousavi
    Papanikolaou, E. G.
    Tournaye, H.
    Camus, M.
    Verpoest, W.
    Donoso, P.
    Van der Elst, J.
    Devroey, P.
    HUMAN REPRODUCTION, 2007, 22 : I5 - I5
  • [10] GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial
    Prapas, Yannis
    Petousis, Stamatios
    Dagklis, Themistoklis
    Panagiotidis, Yannis
    Papatheodorou, Achilleas
    Assunta, Iuliano
    Prapas, Nikos
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 166 (01) : 43 - 46
12345